top of page

PLEASE CONTACT US FOR PRICING

Lumos ViraDx

Lumos ViraDx

ViraDX is a  rapid point-of-care test that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. 

  • PRODUCT INFO

    ViraDx SARS-CoV-2/Flu A+B Rapid Antigen Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from anterior nasal or nasopharyngeal swab specimens obtained from patients who are suspected of COVID-19 by their healthcare provider, within the first five days of onset of symptoms.

     

    Benefits of using ViraDx

    • Efficient 
      • 1 sample - 3 results to aid in a differential diagnosis at the point-of-care
    • Rapid
      • Actionable results at 15 minutes to help improve patient management decisions during the patient visit
    • Instrument-Free
      • User-friendly test procedure for non-lab settings
    • Accurate
      • COVID-19 (Anterior nasal swab): Sensitivity 93.8%; Specificity 100%
      • COVID-19 (Nasopharyngeal): Sensitivity 93.1%; Specificity 100%
      • Flu A: Sensitivity 92.2%; Specificity 94.2%
      • Flu B: Sensitivity 90.0%; Specificity 94.3%

  • Background Information

    Influenza (flu) is a highly contagious acute viral infection of the respiratory tract. It is a communicable disease easily transmitted from person to person through aerosol droplets excreted when sneezing and coughing. There are two main types of influenza - type A and type B.2

    Early differential diagnosis of influenza type A or type B can allow for proper treatment. Early diagnosis and treatment are of particular value in a clinical setting where an accurate diagnosis can assist the healthcare professional with the management of influenza patients who are at risk for complications.3

    COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Similar to influenza, the virus can spread from an infected person's mouth or nose ranging from larger respiratory droplets to smaller aerosols.4 COVID-19 symptoms can range from mild to severe.

    As the early symptoms of COVID-19 are like those of seasonal influenza type A or B, a rapid, point- of-care test can help support the differential diagnosis of COVID-19, influenza A and B.

    • For in vitro diagnostic use.
    • For Rx use only.
bottom of page